Traditional medical approaches to most chronic disease conditions are often very helpful,but limited at the same timeduetoalackofbreakthrough advancements that couldactuallyaddress the root cause of disease. Ongoing development inthefieldofstemcellsandregenerativemedicine is reshaping today’s healthcare platform. As we continue talking about this field, let us introduce R3 Stem Cell,acompany that provides stemcelland regenerative therapies both domestically and internationally.
Handpicked as one of the Most Innovative Companies, R3 Stem Cell was establishedin2012.Wegot in touch with Dr.DavidL.Greene,the CEO of the company. Let’s know more about R3 Stem Cell from this interview.
Take us back to the founding moment when your company began.
R3StemCellbeganin2012duringmy time in the executive program at ASU’s WP Carey Business School. DuringourEntrepreneurialclass,IputtogetheraprojectforaMedicalCenter forStem Cell&LaserTherapythatcould help many thousands of people dealing with chronic,debilitating conditions.
OverthatsemesterIranthebusinessplanthroughProfessors attheASULawSchoolalongwiththeASUexpertsinBusinessAnalytics,Marketing,SupplyChain,Finance, and also the Dean. At the end of the process, R3 Stem Cell was born. Since then the company business modelhasbeenalteredover10times,andthecompanycontinues to grow every year!
Every journey has a few roadblocks and challenges. What were yours? How did you overcome them?
As providers and patients around the worldrealizethatregenerativetherapies workwellandaresafe,theirusehasincreased exponentially.Ontheone hand,thishasbeenfantastic as the “adoption curve” progresses, but it has also created a lot of competition!
Many providers and manufacturers disseminate unrealisticclaims or call their treatments “stemcelltherapy”whenitactuallyisn‘t.Soithasbeenachallengedealingwith unethical competitionspreadinginaccurate information.
How have we dealtwith it?We‘vetakentheapproachofdisseminating accurate educational videos including our Stem Cell Master Class, which includes four hours of information for prospective patients. We started training providers with in-depth education on biologics,supplements, procedure techniques, and realistic expectations for their patients. Also, we make sure our products are top of theline, soproviderscanfeelcomfortableusingthemwithregards to both effectiveness and safety.
Another challenge we’ve faced over the years is when our affiliated providers have gone to biased training and are fed outrightlieswhilethere.This is the main reason I started R3 Medical Training, so providers not only receive accurate, evidence-based information, but also get to learn with real procedures on realpatients!
Can you brief us about your products and services?
R3 Stem Cell and its sister company ReBella Suppliers provides all the needs for regenerativepractices.Implementinga first-rate regenerative practice should be done correctly, or it shouldn‘tbedoneatall.R3providesmarketing,treatment protocols,clinicaltraining,alarge peertopeernetwork, and first-rate biologics as well that have a superior safety record and come from FDACertifiedlabs.
Product options include amniotic allograft, umbilical cord tissue, exosomes, PRP kits, adipose kits, cryogenic freezers, thread lifts, supplements, microneedling devices, and more.
Tell us a few factors that make your company an innovative hub in today’s global market.
As acompany,R3hasworkedveryhardtomeetthe demands of providers and patients looking to incorporate regenerative therapies and improve quality of life. We don’t just offer high-quality regenerative biologics, R3 offers training workshops where providers can learn the clinical skills necessary to become adept in the procedures.
Along withquality biologicsandtraining,R3‘smarketingdivision generates over5,000prospectivepatientleadsevery month. No other regenerative company assists practices through the entire customer journey the way R3 does. Servicesincludemarketing,patientandprovider education,clinicaltraining,andevery kindoffirst–ratebiologicapractice would need to help patients.
Where do you see your company a couple of years from now?
In a couple of years, R3 will grow from 40 affiliates to over 80 in the US, and our International Centers will grow their procedure numbers to over 500per yearcollectively.Regenerative therapiesarethe futureofmedicine,andthegrowth has been and will be exponential!
Along with a remarkable increase in the numbers of procedures,R3MedicalTraining will continue to increase the numbers of courses being offered. Attendees love the hands-on courses includingrealprocedureson realpatients,and we offer veterans and first responders free procedures during the workshops (The R3 Heroes Program). To date we‘vehelpedover100veterans,hopefully,we canhelpover 500inthe next two years!
No Comments